UK Regulator Explains Changes To Pharmacovigilance Rules From 2025

While pharmacovigilance requirements for medicines in the UK will remain “broadly in line” with current rules from 1 January 2025, companies should be aware of changes for some products after this date, the UK’s MHRA says.

Pharmacovigilance
• Source: Shutterstock

New guidance from the UK Medicines and Healthcare products Regulatory Agency sets out how pharmacovigilance requirements will change from 1 January 2025, when the post-Brexit “Windsor Framework” for easing the movement of goods between Great Britain and Northern Ireland comes into effect.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography